Influence of travel burden on tumor classification and survival of head and neck cancer patients
- PMID: 33877433
- DOI: 10.1007/s00405-021-06816-3
Influence of travel burden on tumor classification and survival of head and neck cancer patients
Abstract
Purpose: Cancer patients have to overcome various barriers to obtain diagnostics and treatment at head and neck cancer centers. Travel distance to a specialized hospital may result in psychosocial and financial distress, thus interfering with diagnostics, treatment, and follow-up care. In this study, we have aimed to analyze the association of travel distance with cTNM status, UICC stage at primary diagnosis, and survival outcomes of head and neck cancer (HNC) patients.
Methods: We have analyzed data of 1921 consecutive HNC patients diagnosed between 2014 and 2019 at the head and neck cancer center of the Comprehensive Cancer Center Ulm (CCCU), Germany. Postal code-based travel distance calculation in kilometers, TNM status, and UICC stage were recorded at initial diagnosis. The assembly of travel distance-related groups (short, intermediate, long-distance) has been investigated. Moreover, group-related survival and recurrence analysis have been performed.
Results: In contrast to observations from overseas, no association of travel distance and higher cTNM status or UICC stage at primary diagnosis has been observed. Furthermore, no significant differences for recurrence-free survival and overall survival by travel distance were detected.
Conclusion: In southern Germany, travel distance to head and neck cancer centers seems to be tolerable. Travel burden is not synonymous with travel distance alone but also involves sociodemographic, monetary, and disease-specific aspects as well as accessibility to proper infrastructure of transport and health care system.
Keywords: Cancer; Infrastructure; Telemedicine; Travel distance; Tumor.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany.Cancer Med. 2023 Sep;12(18):18826-18836. doi: 10.1002/cam4.6505. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706654 Free PMC article.
-
Distance Traveled to Head and Neck Cancer Provider: A Measure of Socioeconomic Status and Access.Otolaryngol Head Neck Surg. 2020 Feb;162(2):193-203. doi: 10.1177/0194599819892015. Epub 2019 Dec 3. Otolaryngol Head Neck Surg. 2020. PMID: 31794337
-
Travel distance: Impact on stage of presentation and treatment choices in head and neck cancer.Am J Otolaryngol. 2018 Sep-Oct;39(5):575-581. doi: 10.1016/j.amjoto.2018.06.020. Epub 2018 Jun 28. Am J Otolaryngol. 2018. PMID: 30041985
-
The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature.Oncol Res Treat. 2020;43(10):549-558. doi: 10.1159/000509427. Epub 2020 Sep 18. Oncol Res Treat. 2020. PMID: 32950990
-
Examining the Effect of Travel Distance to Pediatric Cancer Centers and Rurality on Survival and Treatment Experiences: A Systematic Review.J Pediatr Hematol Oncol. 2021 Jul 1;43(5):159-171. doi: 10.1097/MPH.0000000000002095. J Pediatr Hematol Oncol. 2021. PMID: 33625091
Cited by
-
Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany.Cancer Med. 2023 Dec;12(23):21426-21435. doi: 10.1002/cam4.6690. Epub 2023 Dec 1. Cancer Med. 2023. PMID: 38037808 Free PMC article.
-
Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany.Cancer Med. 2023 Sep;12(18):18826-18836. doi: 10.1002/cam4.6505. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706654 Free PMC article.
References
-
- Douthit N, Kiv S, Dwolatzky T, Biswas S (2015) Exposing some important barriers to health care access in the rural USA. Public Health 129(6):611–620. https://doi.org/10.1016/j.puhe.2015.04.001 - DOI - PubMed
-
- Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L (2015) Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist 20(12):1378–1385. https://doi.org/10.1634/theoncologist.2015-0110 - DOI - PubMed - PMC
-
- Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D et al (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22. https://doi.org/10.1007/s00520-011-1270-1 - DOI - PubMed
-
- Xu Z, Becerra AZ, Justiniano CF, Boodry CI, Aquina CT, Swanger AA et al (2017) Is the distance worth it? patients with rectal cancer traveling to high-volume centers experience improved outcomes. Dis Colon Rectum 60(12):1250–1259. https://doi.org/10.1097/DCR.0000000000000924 - DOI - PubMed
-
- Nipp RD, Lee H, Gorton E, Lichtenstein M, Kuchukhidze S, Park E et al (2019) Addressing the financial burden of cancer clinical trial participation: longitudinal effects of an equity intervention. Oncologist 24(8):1048–1055. https://doi.org/10.1634/theoncologist.2019-0146 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical